Intuitive Surgical (NasdaqGS:ISRG) received U.S. FDA clearance for its da Vinci 5 system for specific minimally invasive cardiac procedures. The new indication includes uses such as mitral valve ...

Intuitive Surgical fared remarkably well during the pandemic even as many hospitals struggled with tight capital budgets and elective surgeries were almost nonexistent during the COVID-19 peak. Now, ...

David J. Rosa, CEO, opened with recognition of Gary Guthart’s transition to Executive Chair, stating his excitement to lead Intuitive forward and emphasizing the company’s strong financial metrics for ...

Intuitive Surgical's flagship product helps surgeons with a broad range of procedures.

In the past 12 months, shares of Intuitive Surgical have fallen by around 16%.

Intuitive Surgical ISRG reported third-quarter 2024 adjusted earnings per share (EPS) of $1.84, which beat the Zacks Consensus Estimate of $1.65 by 11.5%. The bottom line improved 26% year over year.

Artificial intelligence isn't performing surgery yet, but if (when?) it does, these two companies are likely to be at the ...

Intuitive Surgical ISRG delivered robust 2025 results, beating estimates on both counts. Total revenues rose 20.5% year over ...

Intuitive Surgical Inc (NASDAQ:ISRG) reports financial results for the fourth quarter on Thursday. Here's a rundown of the report.

Intuitive Surgical ISRG reported first-quarter 2024 adjusted earnings per share (EPS) of $1.50, which beat the Zacks Consensus Estimate of $1.40 by 7.1%. The bottom line improved 22% year over year.